These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24126921)

  • 1. An update on the importance of monitoring serum magnesium in advanced disease patients.
    Centeno C; López Saca JM
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):396-405. PubMed ID: 24126921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term proton pump inhibitor treatment may cause hypomagnesaemia in critically ill patients - a pilot study.
    Krzych ŁJ; Łój P; Nowak T; Kazura W; Knapik P
    Acta Biochim Pol; 2017; 64(3):499-501. PubMed ID: 28651024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors and severe hypomagnesaemia.
    Cundy T; Mackay J
    Curr Opin Gastroenterol; 2011 Mar; 27(2):180-5. PubMed ID: 20856115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypomagnesaemia due to use of proton pump inhibitors--a review.
    Kuipers MT; Thang HD; Arntzenius AB
    Neth J Med; 2009 May; 67(5):169-72. PubMed ID: 19581665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor associated hypomagnasaemia - a cause for concern?
    Begley J; Smith T; Barnett K; Strike P; Azim A; Spake C; Richardson T
    Br J Clin Pharmacol; 2016 Apr; 81(4):753-8. PubMed ID: 26613375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomagnesaemia/hypokalemia associated with the use of esomeprazole.
    Negri AL; Valle EE
    Curr Drug Saf; 2011 Jul; 6(3):204-6. PubMed ID: 22122397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomagnesaemia in oncologic patients: to treat or not to treat?
    Wolf FI; Trapani V; Cittadini A; Maier JA
    Magnes Res; 2009 Mar; 22(1):5-9. PubMed ID: 19441269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium depletion in patients receiving cisplatin-based chemotherapy.
    Hodgkinson E; Neville-Webbe HL; Coleman RE
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):710-8. PubMed ID: 17100159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.
    Hess MW; de Baaij JH; Broekman M; Bisseling TM; Haarhuis B; Tan A; Te Morsche R; Hoenderop JG; Bindels RJ; Drenth JP
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1178-85. PubMed ID: 27086738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review: hypomagnesaemia induced by proton pump inhibition.
    Hess MW; Hoenderop JG; Bindels RJ; Drenth JP
    Aliment Pharmacol Ther; 2012 Sep; 36(5):405-13. PubMed ID: 22762246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could proton pump inhibitors cause cancer?
    Rosch PJ
    Arch Intern Med; 2010 Oct; 170(19):1775-6. PubMed ID: 20975029
    [No Abstract]   [Full Text] [Related]  

  • 16. Lansoprazole-induced hypomagnesaemia.
    Krupa LZ; Fellows IW
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24414180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous magnesium infusions in the management of systemic anti-cancer therapy-related hypomagnesaemia.
    Mateo-Carrasco H; Kostrzynski O; Ndefo O; Stapley S; Davies E; Agarwal R
    Int J Clin Pharm; 2017 Aug; 39(4):657-661. PubMed ID: 28444546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomagnesaemia.
    Drug Ther Bull; 2013 Mar; 51(3):33-6. PubMed ID: 23482516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and hypomagnesemia.
    Lajer H; Daugaard G
    Cancer Treat Rev; 1999 Feb; 25(1):47-58. PubMed ID: 10212589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors: is there a real link?
    Sarikaya M; Filik L; Ergul B; Doğan Z
    Gastroenterol Nurs; 2013; 36(2):145-8. PubMed ID: 23549219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.